Likewise, in the comparison of the control and the CP group, the significantly upregulated LRATD2 is the main inducer of neuroendocrine tumor, which induces glioma by the cell cycle or Akt/GSK-3β/βpathways [47,48,49]. This evidence concerns the gene GSK3B and central nervous system cancer.